Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Otsuka Pharmaceutical Development & Commercialization, Inc..
Real, source-linked trial activity for Otsuka Pharmaceutical Development & Commercialization, Inc.: 5 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Oct 8, 2026. Source-linked, daily-refreshed.
PHASE3 4N/A 1
Newest Otsuka Pharmaceutical Development & Commercialization, Inc. trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | Early Access Program for Ulefnersen in Children, Adolescents and Adult | N/A | AVAILABLE | ↗ |
| 43d ago | A Trial of the Safety and Tolerability of SEP-363856 in Adults With Ge | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 51d ago | Trial of Sibeprenlimab in Children and Adolescents With Immunoglobulin | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 52d ago | A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Ad | Ph 3 | RECRUITING | ↗ |
| 57d ago | A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adu | Ph 3 | RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Otsuka Pharmaceutical Development & Commercialization, Inc. (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.